1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Immune Complex Mediated Membranoproliferative Glomerulonephritis: new trials by email Literature Review of Immune Complex Mediated Membranoproliferative Glomerulonephritis trials Research Report on Immune Complex Mediated Membranoproliferative Glomerulonephritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN Danicopan - C3 Glomerulonephritis, Dense Deposit Disease | Phase 2 | Completed | Alexion Pharmaceuticals, Inc. | 6 | 2017-08-09 | 2021-11-04 |
Glomerulonephritis, Membranoproliferative (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glomerulonephritis (1) · Immune System Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nephritis (1) · Urogenital Diseases (1) · Urologic Diseases (1)
danicopan (1)
Alexion Pharmaceuticals, Inc. (1)
Australia (1) · Belgium (1) · Netherlands (1)
2016 (1)